benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucous Membrane Topical Solution
- RxCUI
- 1362704
- RxNorm name
- benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucous Membrane Topical Solution
- Display name
- Benzocaine/Cetylpyridinium/Menthol (Mucosal)
- Full name
- benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucous Membrane Topical Solution
- Term type
- SCD
- Status
- Active
- Strength
- 2-0.1-0.5%
- Dose form
- Sol
- Route
- Mucosal
- Updated
- 2026-07-24 06:53:18
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 012013
- Active start
- 012013
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| benzocaine | 20 MG / 1 ML | benzocaine | benzocaine |
| cetylpyridinium chloride | 1 MG / 1 ML | cetylpyridinium | cetylpyridinium chloride |
| menthol | 5 MG / 1 ML | menthol | menthol |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Mucous Membrane Topical Solution | 316956 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| benzocaine | 1399 |
| cetylpyridinium | 2286 |
| menthol | 6750 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucous Membrane Topical Solution | 1 | NAMES |
| RxNorm Name | benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucous Membrane Topical Solution | 1 | NAMES |
| RxNorm Synonym | benzocaine 2 % / cetylpyridinium chloride 0.1 % / menthol 0.5 % Mucous Membrane Topical Solution | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| RxCUI | 1362704 | 1 | CODES |
| MMSL_CODE | CD27957 | 1 | CODES |
UNII Substances#
No records found.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| ed70911b-9da8-4e1d-97fa-66b18d28516a | benzocaine 2 % / menthol 0.5 % / cetylpyridinium chloride 0.1 % Mucous Membrane Topical Solution [PSN] · benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucous Membrane Topical Solution [SCD] · benzocaine 2 % / cetylpyridinium chloride 0.1 % / menthol 0.5 % Mucous Membrane Topical Solution [SY] | 3 | 6 | Llorens- Orasep Liquid 503 | 20251231 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 092c246f-db0e-4250-8245-a6799e793026 | ACTISEP ® SOLUTION | Actipharma, Inc | 20181205 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | D04AB | Anesthetics for topical use | ATC1-4 | benzocaine | |
| ATC | R02AD | Anesthetics, local | ATC1-4 | benzocaine | |
| ATC | B05CA | Antiinfectives | ATC1-4 | cetylpyridinium | |
| ATC | R02AA | Antiseptics | ATC1-4 | cetylpyridinium | |
| ATC | N01BA | Esters of aminobenzoic acid | ATC1-4 | benzocaine | |
| ATC | C05AD | Local anesthetics | ATC1-4 | benzocaine | |
| ATC | D09AA | Medicated dressings with antiinfectives | ATC1-4 | cetylpyridinium | |
| ATC | D08AJ | Quaternary ammonium compounds | ATC1-4 | cetylpyridinium | |
| FDASPL | N0000185508 | Standardized Chemical Allergen | EPC | has_epc | benzocaine |
| FDASPL | N0000184306 | Cell-mediated Immunity | PE | has_pe | benzocaine |
| FDASPL | N0000175629 | Increased Histamine Release | PE | has_pe | benzocaine |
| MEDRT | D001566 | Benzocaine | CHEM | has_ingredient | benzocaine |
| MEDRT | D002594 | Cetylpyridinium | CHEM | has_ingredient | cetylpyridinium chloride |
| MEDRT | D002594 | Cetylpyridinium | CHEM | has_ingredient | cetylpyridinium |
| MEDRT | D008610 | Menthol | CHEM | has_ingredient | menthol |
| MEDRT | D001424 | Bacterial Infections | DISEASE | ci_with | benzocaine |
| MEDRT | D002056 | Burns | DISEASE | may_treat | benzocaine |
| MEDRT | D003773 | Dental Plaque | DISEASE | may_prevent | cetylpyridinium chloride |
| MEDRT | D003773 | Dental Plaque | DISEASE | may_prevent | cetylpyridinium |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | menthol |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | benzocaine |
| MEDRT | D004433 | Earache | DISEASE | may_treat | benzocaine |
| MEDRT | D005401 | Fissure in Ano | DISEASE | may_treat | benzocaine |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | benzocaine |
| MEDRT | D006561 | Herpes Simplex | DISEASE | may_treat | benzocaine |
| MEDRT | D019226 | Oral Ulcer | DISEASE | may_treat | benzocaine |
| MEDRT | D010032 | Otitis Externa | DISEASE | may_treat | benzocaine |
| MEDRT | D010033 | Otitis Media | DISEASE | may_treat | benzocaine |
| MEDRT | D010146 | Pain | DISEASE | may_treat | menthol |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | benzocaine |
| MEDRT | D011537 | Pruritus | DISEASE | may_treat | benzocaine |
| MEDRT | D012871 | Skin Diseases | DISEASE | may_treat | menthol |
| MEDRT | D014098 | Toothache | DISEASE | may_treat | benzocaine |
| MEDRT | N0000000069 | Calcium Channel Antagonists | MOA | has_moa | menthol |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | benzocaine |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | menthol |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | benzocaine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 20 MG/ML / 1 MG/ML / 5 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| NAMES | Prescribable Synonym | benzocaine 2 % / menthol 0.5 % / cetylpyridinium chloride 0.1 % Mucous Membrane Topical Solution |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |